CIA and industry officials said advanced AI models are accelerating threats, pressuring agencies to rethink how they manage risk and respond to vulnerabilities.
Agencies are increasingly turning to the governmentwide buying program for AI tools as officials pitch both lower costs and broader workforce adoption.
The House Homeland Security Committee was briefed on Anthropic's Mythos as officials and executives weigh how frontier systems could reshape vulnerability discovery, national security competition and access across federal agencies.
The effort is aimed at helping eligibility staff interpret complex federal rules and manage increasing administrative demands tied to SNAP policy changes.
Defense Under Secretary for Research and Engineering Emil Michael said new agreements with Big Tech companies are a “counterstatement” to the ongoing Anthropic-Pentagon conflict as the agency prioritizes flexible contracts.
Draft policy language under review would assert the government’s authority to decide how tech it buys gets used, as officials debate guardrails and vendor influence.
A new survey of federal IT leaders shows growing interest in more autonomous AI tools as pilot activity accelerates, even as governance, data and oversight gaps persist across government.
The Centers for Medicare and Medicaid Services official also said the Trump administration’s efforts to combat fraud in government are enabling her to “push the needle” with using the technology.
After a failed first rollout, the department reworked how it builds and deploys tech, bringing frontline staff into the process and scaling a system that’s now handling millions of renewals.
“When there is support and excitement, then you can do magic,” Pavan Pidugu, the Transportation Department’s chief digital and information officer, said about engaging personnel across the agency to drive meaningful IT modernization.
Jeffrey Koses has spent decades inside GSA’s acquisition system, moving from entry-level furniture purchasing to policy leadership and now overseeing a sweeping rewrite of the Federal Acquisition Regulation aimed at simplifying procurement and increasing flexibility for contracting officers.
COMMENTARY | Following massive workforce reductions — and a $165.6 billion hit to the U.S. economy — federal managers are struggling to integrate AI as low engagement collapses across agencies.
The move suggests the Trump administration is easing its stance on the AI company, which faced a Pentagon supply chain risk designation and phaseout directive.
The first-of-its-kind pilot could lead to speedier regulatory approval of medical drugs and devices and potentially reduce “20, 30, 40% of overall clinical trial time,” according to FDA Chief Artificial Intelligence Officer Jeremy Walsh.